Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuroblastoma]

T Sawada1, H Komatsu, C Shirai

  • 1Dept. of Pediatrics, Kyoto Prefectural University of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 1, 1995
PubMed
Summary

Neuroblastoma treatment is tailored to patient age, stage, and specific prognostic factors. Recent advances in supportive therapies have significantly improved outcomes for this highly malignant tumor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A study on contamination from Legionella spp. at a home for the elderly in Toyohashi City].

[Nihon koshu eisei zasshi] Japanese journal of public health·2002
Same author

Disseminated retinoblastoma successfully treated with myeloablative chemotherapy--implication for molecular detection of minimal residual disease.

Bone marrow transplantation·1999
Same author

[A case of primary malignant lymphoma of the bladder].

Hinyokika kiyo. Acta urologica Japonica·1998
Same author

The mechanism of sensitizing effect of a triazine dye, cibacron blue F3GA, on methicillin-resistant Staphylococcus aureus to oxacillin.

Hiroshima journal of medical sciences·1998
Same author

A triazine dye, cibacron blue F3GA, decreases oxacillin resistance levels in methicillin-resistant Staphylococcus aureus.

Antimicrobial agents and chemotherapy·1998
Same author

IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury.

Journal of immunology (Baltimore, Md. : 1950)·1995

Area of Science:

  • Pediatric Oncology
  • Cancer Biology

Context:

  • Neuroblastoma is a common, highly malignant pediatric tumor.
  • Historically, survival rates were low, but have improved with modern treatments.

Purpose:

  • To present current neuroblastoma treatment regimens.
  • To highlight the importance of personalized treatment selection based on prognostic factors.

Summary:

  • Treatment selection depends on patient age, tumor stage, and biological factors like N-myc amplification and chromosome anomalies.
  • Less intensive regimens are used for young children without adverse factors, while intensive protocols are employed for older children and those with unfavorable factors.
  • Advanced supportive therapies, including antiemetics and G-CSF, enhance treatment tolerance and efficacy.

Related Experiment Videos

Impact:

  • Improved prognosis and survival rates for neuroblastoma patients.
  • Establishes a framework for individualized neuroblastoma treatment strategies.
  • Demonstrates the critical role of supportive care in managing aggressive cancers.